Comparison

VidistarViewer vs MobiPACS Pro

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

VidistarViewer

Access and review medical images, videos, and diagnostic reports instantly on your mobile device. Enhance patient understanding by showing them their studies directly. Supports various diagnostic DICOM studies for comprehensive review.

Highlights
  • Instant access to medical images and reports
  • View still images and video clips
  • Review diagnostic DICOM studies
  • Access patient information
  • Review studies from any location
  • Patient engagement tool
Features
Read full description

VidistarViewer™ offers medical professionals instant access to their medical images and reports from their mobile Apple device(s). With VidistarViewer™, users may view still images, video clips, patient information, diagnostic reports, and review their diagnostic DICOM studies (i.e. echos, vascular studies, OBGYN, nuclear, cath, angio, etc.). Review Studies from Anywhere VidistarViewer™ includes similar functionality to VidiStar's web-solutions, and allows users to review studies and reports regardless of location. Engage Your Patients Use your iPad to show your patient their diagnostic study and enhance their engagement in their plan of care by educating them on their condition, thus heightening their understanding and furthering your patient-relationship.

About

MobiPACS Pro

Features
Read full description

MobiPACS Pro medical image viewer is quickly becoming the next generation in mobile medical image viewing by combining multi-modality imaging with individualized physician workflow. MobiPACS Pro allows facilities to retrieve multi-modality images from their existing MobiPACS Pro server or a 3rd party PACS server and display the content on the iPad and iPhone. Additionally, the MobiPACS Pro server can receive other images/file formats, such as JPG, BMP, and PDF from the adjacent information systems and display the files in an organized fashion for general physicians to view. Features include: • Support for all modalities (CR, ECG/EKG, DR, CT, MR, US, XA, NM, etc) • Quick layout adjustment (1x1, 2x1, etc) • Fast image and data access over 3G or Wi-Fi • Pan • Zoom • Window Level • Manual Slider bar • Multi-Server capable • Measurement (e.g. length) • DICOM PDF • Auto Cine • Mammography Hanging Protocol • Support Tomosynthesis • Studies Comparison • Commentary feature (Audio & freehand writing) • Query images cross-sites in a hospital network This application requires the MobiPACS Pro server and this app installed on iPad 4th or later model can be used for trained physician’s CT/MR diagnosis or referring purpose. Ver 1.2.5 1. Support Rotate/Flip Images 2. Support Ratio measurement 3. Support Multiple Measurements Mode Ver 1.2.4 1. Change the patient name's display format Ver 1.2.3 1. Support HTTPs connection Ver 1.2.2 1. Study Comparison mode supports DICOM PDFs 2. Study Comparison mode treats CR and DX as the same modality. Ver 1.1.20 1. Support Concurrent License Mode Ver 1.1.18 1. Support iOS 14 Ver 1.1.15 1. Support iOS 13 2. NetConference Ver 1.1.8 1. Support iPhone X, iPad Pro 12.9-inch (3rd generation) 2. Support iOS 12 Ver 1.1.5 1. MobiPACS Multi Ver 1.1.3 1. Integration with ShareMi Server Ver 1.1.1 1. Support iOS 7 2. Support Bar Code Scanning Ver 1.0.8 1. Support Window Level, Line Measurement and Cine Loop function for iPhone version. 2. Image layout settings will be saved and recalled next time automatically. 3. Multi-frame Images will start the cine loop automatically after downloading. 4. Add "Play", "Previous frame" and "Next frame" buttons. 5. Add "When you close application, close the study automatically" setting. 6. Add "When you close the study, delete the cache automatically" setting. Ver 1.0.4 1. Support iOS 6 and iPhone 5 2. Support Cine Loop 3. Support Line Measurement Ver 1.0.3 1. Support iDO Gateway Server Ver 1.0.2 1. Support Evidence Document (such as PDF, QuickTime, and MPEG4 Video) 2. Integration with the App, "Dr. Reminder" Ver 1.0.1 1. Support integration with Web Page or 3rd party App via URL Schemes

Screenshots

VidistarViewer4 screens
MobiPACS Pro1 screens

Verdict

The call

The clearest difference is update cadence: MobiPACS Pro at every 6 months against VidistarViewer's every 30 months. On price, ads, in-app purchases and device support there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

UpkeepUpdate frequency

VidistarViewer ships an update every 30 months, MobiPACS Pro every 6 months. The most recent releases landed on June 28, 2026 and September 9, 2026 respectively.

Scorecard1 real difference · 9 level
VidistarViewer versus MobiPACS Pro: the parameters behind the verdict, then further details
ParameterVidistarViewerMobiPACS Pro
PriceFreeFree
Rating3.0 (2 ratings) — better—
Positive reviews50.0% of reviews—
Number of ratings2 — better—
Update frequencyEvery 30 monthsEvery 6 months — better
AdsNoNo
In-app purchasesNoNo
MonetizationFree—
DevicesiPhone, iPad, iPodiPhone, iPad, iPod
Requires iOS13.012.1 — better
Further details — not scored
Size1 MB12 MB
Age rating17+4+
DeveloperVidiStar, LLCEBM Technologies, Incorporated.

In-app purchases

None

VidistarViewer

No in-app purchases

None

MobiPACS Pro

No in-app purchases

Questions

Is VidistarViewer free?
VidistarViewer is free to download, with no in-app purchases.
Is MobiPACS Pro free?
MobiPACS Pro is free to download, with no in-app purchases.
Do VidistarViewer or MobiPACS Pro have ads?
Neither VidistarViewer nor MobiPACS Pro shows ads.
Which is updated more often, VidistarViewer or MobiPACS Pro?
VidistarViewer ships an update every 30 months, and MobiPACS Pro every 6 months. Most recently, VidistarViewer was updated on June 28, 2026 and MobiPACS Pro on September 9, 2026.

Other comparisons